K.J. Harrison & Partners’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-6,040	Closed	-$268K	–	145
2018 Q3	$268K	Sell	6,040 -50	-0.8%	-$2.22K	0.07%	164
2018 Q2	$358K	Buy	+6,090	New	+$358K	0.1%	153
2018 Q1	–	Sell	-23,525	Closed	-$552K	–	170
2017 Q4	$552K	Buy	+23,525	New	+$552K	0.19%	123